Earnings History Data for Innoviva, Inc. (INVA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Innoviva, Inc.
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | INVA | Innoviva, Inc. | 1,210 | 0.02 | 0.00 | 0.98 | Innoviva GAAP EPS of $0.02, revenue of $89.51M beats by $12.59M [11/7/2024 2:37 AM] |
20.00 | 0.08 (0.40%) |
19.92 | 0.0 (0.00%) |
13.31 - 20.37 | 681,559 | 370,000 | 31,904 | ||
| 09-05-2023 | AH | 4:05 PM ET (May 9) |
INVA | Innoviva, Inc. | 795.71 | 0.42 | 0.00 | 0.42 | Innoviva GAAP EPS of $0.51, revenue of $76.37M [5/9/2023 5:45 PM] |
12.22 | 0.66 (5.75%) |
0.0 | 0.0 (0.00%) |
10.64 - 16.67 | 734,433 | 430,000 | 0 | |
| 28-02-2023 | AH | INVA | Innoviva, Inc. | 859.73 | 0.25 | 0.41 | 0.55 | InnovivaEPS of -$0.98, revenue of $65.8M beats by $6.95M [2/28/2023 4:59 PM] |
11.37 | -0.71 (-5.84%) |
0.0 | 0.0 (0.00%) |
11.14 - 20.71 | 1,460,031 | 550,000 | 0 | ||
| 28-07-2021 | AH | 4:05 PM ET (Jul 28) |
INVA | Innoviva, Inc. | 1,336 | 0.90 | 0.29 | 0.00 | 14.10 | 0.46 (3.37%) |
13.85 | 0.21 (1.54%) |
9.21 - 14.42 | 657,886 | 390,000 | 501 | ||
| 28-04-2021 | AH | 4:05 PM ET (Apr 28) |
INVA | Innoviva, Inc. | 1,196 | 0.84 | -0.01 | 0.00 | Innoviva reports Q1 results [4/28/2021 5:24 PM] |
11.68 | 0.09 (0.78%) |
11.80 | 0.21 (1.81%) |
9.21 - 15.62 | 359,227 | 470,000 | 12,523 | |
| 03-02-2021 | AH | 4:30 PM ET (Feb 3) |
INVA | Innoviva, Inc. | 1,250 | 0.48 | 0.40 | 0.42 | Innoviva reports Q4 results [2/3/2021 4:21 PM] |
12.51 | 0.06 (0.48%) |
12.93 | 0.48 (3.86%) |
7.58 - 15.62 | 457,822 | 449,146 | 107 | |
| 29-07-2020 | AH | 4:05 PM ET (Jul 29) |
INVA | Innoviva, Inc. | 1,410 | 0.69 | 0.32 | 0.34 | Innoviva EPS beats by $0.37 [7/29/2020 4:50 PM] |
13.60 | 0.31 (2.33%) |
13.65 | 0.36 (2.71%) |
7.58 - 15.62 | 288,844 | 451,566 | 200 | |
|
|
||||||||||||||||||